On 1 October, Allergy UK and Anaphylaxis UK officially came together to form Allergy UK incorporating Anaphylaxis UK. By combining our expertise, resources, shared commitment and passionate teams, we now can create a stronger,…
Read more
The UK’s first needle-free adrenaline nasal spray, EURneffy® 1mg, is now available on prescription for younger children at risk of serious allergic reactions. The newly available 1 mg dose is licensed for…
Read more
Photo credit: Mast cells – Zoe Whyte, Mast cells, used with permission Mast cell diseases can go unnoticed by almost everyone, yet be unmistakable to the person living with one. Today, on…
Read more
Leo was born on 14 October 1992 and grew up as a fit, active young man who loved football, rugby and the outdoors. Although he had asthma as a child, there was…
Read more
Transforming Allergy Care:The First National Allergy Capability Framework is launched The British Society for Allergy & Clinical Immunology (BSACI) has launched the National Allergy Capability Framework (ACF), a landmark initiative designed to…
Read more
2026 has been a landmark year for the allergic and anaphylactic community. From a stronger united voice for people living with allergy to major progress in schools, national policy and treatment options,…
Read more
Robbie Epsom, Anaphylaxis UK Ambassador I advise on sustainability for a living, and increasingly on AI. But the third thing I talk about is anaphylaxis. I have lived with a life-threatening tree…
Read more
Leaving home without your adrenaline is non-negotiable. Despite the known risks, hidden barriers such as perceived social stigma mean that packing an adrenaline device often slips down the priority list for young…
Read more
Living with serious allergies shouldn’t mean living on the sidelines. Whether it is a child navigating the school dining hall, an adult enjoying a social gathering, a colleague attending a work lunch,…
Read more